Loading...
XMAD
ALB
Market cap5.75bUSD
Apr 24, Last price  
83.68EUR
Name

Corporacion Financiera Alba SA

Chart & Performance

D1W1MN
XMAD:ALB chart
P/E
51.18
P/S
35.57
EPS
1.64
Div Yield, %
1.15%
Shrs. gr., 5y
0.64%
Rev. gr., 5y
-13.11%
Revenues
141m
-34.08%
00552,112,000412,593,000512,840,000388,724,000433,503,000-278,581,000292,442,000323,635,000290,175,000438,100,000546,400,000252,000,000284,700,00080,900,000576,000,000638,600,000213,900,000141,000,000
Net income
98m
-58.12%
444,269,000918,305,000525,261,000361,391,000390,556,000419,370,000406,174,000-299,434,000226,917,000241,328,000269,567,000407,800,000474,100,000154,400,000179,200,000-105,900,000302,700,000436,400,000234,000,00098,000,000
CFO
113m
-7.61%
193,076,000-57,357,000-109,237,000162,767,00061,456,000-34,393,000522,267,000135,832,00080,508,00042,592,00073,423,000135,600,00043,100,000159,700,000231,100,000196,000,000183,500,00098,300,000121,800,000112,528,000
Dividend
Jun 21, 20240.96 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in 1986 and headquartered in Madrid, Spain, Corporación Financiera Alba, S.A. operates as a private equity and venture capital firm. The company specializes in various stages of financing, offering early, mid, and late-stage venture capital, as well as growth and emerging growth funding primarily to middle-market and established enterprises. Its investment portfolio encompasses publicly traded and unlisted equities, in addition to real estate assets. CFA targets a diverse array of sectors, including consumer discretionary (such as media, retailing, and distribution), financial services, healthcare (encompassing pharmaceuticals, biotechnology, and life sciences), and industrials (covering capital goods, commercial and professional services, engineering, and environmental services). Further areas of interest include information technology, materials (like construction materials, metals, and mining), and telecommunications. The firm's strategy focuses on direct equity investments, particularly within Spanish public and private companies, typically acquiring minority stakes with a long-term investment outlook. A preference is shown for securing a Board position in its listed company investments.
IPO date
Nov 30, 1989
Employees
633
Domiciled in
ES
Incorporated in
ES

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT